GlaxoSmithKline TV Commercials
WEBWatch, interact and learn more about the songs, characters, and celebrities that appear in your favorite GlaxoSmithKline TV Commercials. Watch the commercial, share it with friends, then discover more great GlaxoSmithKline TV commercials on iSpot.tv
Wayne Gretzky has a face-off with his younger self in new GSK ad
WEBOct 30, 2023 · Wayne Gretzky has a conversation with an AI-generated, younger version of himself, who aims to warn him about the dangers of RSV in a new ad.
Cut Short by RSV: GSK's compelling ad ties into recent FDA approval
WEBMay 8, 2023 · Following the Food and Drug Administration’s approval of Arexvy, the first vaccine for respiratory syncytial virus (RSV), GSK is marketing while the iron is hot. The British drugmaker recently rolled out a powerful ad …
US FDA approves GSK’s AREXVY, the world’s first respiratory …
WEBMay 3, 2023 · Respiratory syncytial virus vaccine, adjuvanted, contains a recombinant subunit prefusion RSV F glycoprotein antigen (RSVPreF3) combined with GSK’s proprietary AS01 E adjuvant. In the US, AREXVY is indicated for the prevention of RSV-LRTD in individuals 60 years of age and older.
GSK launches dramatic RSV awareness ad - Fierce Pharma
WEBMay 3, 2023 · UPDATED: Gearing up for key approvals, GSK projects 'Shingrix-like' sales for its RSV vaccine. That “help” is no doubt’s GSK’s vaccine, Arexvy, which nabbed an historic FDA approval on ...
GSK warns that 'shingles is sleeping' in new ad campaign - Fierce …
WEBOct 31, 2022 · GSK has launched a new television ad campaign called “Shingles is Sleeping” to promote awareness of the risks of the shingles virus. Airing in English and Spanish, the ad is part of a robust...
GSK announces positive topline data on co-administration of …
WEB2 days ago · The Control group received GSK’s RSV vaccine at day 31. 1,2 RZV second dose was administered at day 61 for both groups. 1,2 The primary endpoint was the non-inferiority of the humoral immune responses to GSK’s RSV vaccine and RZV when co-administered compared to when administered at separate visits. 1,2 Key secondary endpoints included ...
New data for AREXVY, GSK’s RSV vaccine, show potential to help …
WEBOct 25, 2023 · GSK plc (LSE/NYSE: GSK) today announced positive preliminary results from its phase III trial [NCT05590403] evaluating the immune response and safety of AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) in adults aged 50 to 59, including those at increased risk of respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD ...
GSK Announces Positive Topline Data on Co-Administration of
WEB1 day ago · The Control group received GSK’s RSV vaccine at day 31. 1,2 RZV second dose was administered at day 61 for both groups. 1,2 The primary endpoint was the non-inferiority of the humoral immune responses to GSK’s RSV vaccine and RZV when co-administered compared to when administered at separate visits. 1,2 Key secondary endpoints included ...
GSK Canada’s New RSV Vaccine Ad Features Wayne Gretzky
WEBOct 31, 2023 · GlaxoSmithKline (GSK) Canada has roped in both older and younger versions of Wayne Gretzky for a new ad for its respiratory syncytial virus (RSV) vaccine Arexvy. The 30-second video ad features a young, AI-generated Wayne Gretzky cautioning his older self today about the dangers of RSV, particularly for older adults.
- Some results have been removed
Skip to content